Connect with us

News

Powerful short film from Future Fertility uniquely captures the emotional journey of fertility treatment

Published

on

The path to parenthood isn’t always as straightforward as one hopes.

A new short film, “The Other Mothers”, created by fertility AI pioneer Future Fertility and digital marketing agency WeThink Nordic, aims to profile the emotional perspectives of patients going through fertility treatments.

“The Other Mothers” builds upon the already growing social movement around patients coming forward to speak out about their experiences, hardships, successes, and failures, helping to normalise discussions about the challenges that hopeful parents endure on their quest to conceive.

WeThink’s concept was guided by a voiceover script penned by a writer who had gone through her own intense fertility, leading to her first child.

Almost by fate, the woman who recorded the spoken voiceover had also undergone IVF treatments and recognised those same feelings reflected in the script.

“Echoing the many posts we’d dug through on online forums, we were touched by the wide range of emotions that such a difficult period brings on and knew that our film had to capture that reality as best as it could,” says Thomas Bo Nielsen, WeThink Nordic’s Creative Director.

“We felt extremely grateful that we were able to materialise our creative concept in a way that’s undoubtedly authentic – which is super important to us when covering a topic that resonates so strongly with a large number of people across the world.”

“Undergoing fertility treatment, whether it’s IVF or egg freezing, is so emotionally and physically taxing, and so many patients carry the mental burden of it alone,” adds Ghita Holst, Partner at WeThink Nordic.

“They often feel uncomfortable about opening up about their experience because it still seems like a taboo subject to talk about in many social circles.”

The film pushes this narrative front and centre, grounding the audience in the emotional pressure experienced by patients undergoing the fertility process and the common feeling that they need to portray a positive disposition for the benefit of others.

“Two pink lines isn’t something we just get.

“We get the uncertainty, the anxiety, the experimenting, the pretending that we’re ‘okay’…that we’re so happy for the women whose path to parenthood turned out differently.”

Beyond the messaging, what makes the film even more impactful is the realism brought to the story via images of actual patients (featuring family, friends, and employees who have gone through the process).

This is strengthened by the participation of Future Fertility’s partner clinics worldwide, who support real patients with these challenges every day.

“There was an incredible sense of community in producing this video,” said Kirsten Anwender, Future Fertility’s Director of Marketing.

“We’re grateful to our patient contributors, who were so generous in entrusting us to share their deeply personal stories with the world.

“Our clinic partners also instantly connected with our vision and were excited to take part. WeThink developed a great concept that truly struck a chord with everyone.”

For fertility patients who were invited to preview the film, the message certainly hit home.

“It’s a really powerful video,” says Heather, one of the film’s IVF patient contributors.

“The first time I saw the final cut, I had to watch it a few times in a row and let the emotions just roll over me.

“It can be so hard to look back at that time because you feel so alone and scared. It was nice to see my experience mirrored and narrated with such care.”

“Like many couples, we didn’t know we would have difficulty conceiving until we tried,” comments Mamiko, another IVF patient who was featured.

“The video captures the overwhelming feeling of uncertainty that impacted many aspects of our lives.”

Two-time IVF mum Ayla reflects: “To me, the video really illustrates the loss of the care-free aspects of conception, the loss of the pleasant “surprise”.

“How you resent having to rely on the science but are also in awe of it and grateful for it.

“How, when you’re lucky enough to end up with a baby in your arms, the differences and discomforts of your journey to get there fade into the background again.”

“The Other Mothers” leaves the audience with a closing message of hope, highlighting the advancements in fertility science and technology that are continuing to improve outcomes and access.

It also honours the tireless, amazing embryologists, providers and clinicians that work diligently to achieve results for their patients.

Future Fertility has been working to close the gaps in fertility science as the first company to provide personalised egg quality assessments for egg freezing and IVF patients, leveraging the power of artificial intelligence to analyse images of each individual egg.

“Being patient-centred is very important in fertility care, and as a whole, the industry has quite a long way to go to achieve this fully,” says Nicole Condon, CEO of TRIO Fertility and Founder of EVOLVE Egg Freezing Clinic – both clinics being early adopters of Future Fertility’s technology.

“Patients deserve to be at the centre of their care, and tools like this enable clinics to empower patients with personalised insights so they can be more informed and more engaged in their treatment decisions.”

As the demand for egg freezing and IVF treatments continues to grow globally, advancements in fertility technology can assist clinics in optimising treatments through precision medicine and providing patients with greater access to care by making fertility journeys more efficient.

Menopause

AI maps how reproductive organs age differently during menopause

Published

on

An AI atlas has mapped how reproductive organs age through menopause, with the ovaries, vagina and uterus changing on different timelines.

To better understand how this process affects health, researchers at the Barcelona Supercomputing Center developed what they describe as the first large-scale atlas of female reproductive system ageing, using artificial intelligence.

The team combined 1,112 tissue images from 659 samples, covering 304 women aged 20 to 70, with gene expression data from thousands of genes.

This allowed them to reconstruct how seven key reproductive organs, including the uterus, ovary, vagina, cervix, breast and fallopian tubes, age over time.

The study used the supercomputing power of MareNostrum 5 together with advanced image-recognition methods to process the data.

Using deep learning techniques, the researchers detected visible tissue changes as well as the underlying molecular processes linked to ageing in each organ.

The result was a detailed, organ-by-organ map of the reproductive system’s ageing process.

The researchers found that not all organs age in the same way or at the same speed. The ovaries and vagina showed a more gradual ageing process that begins even before menopause officially starts.

By contrast, the uterus appeared to undergo more sudden changes around the time of menopause.

Even within a single organ, different tissues aged at different rates. In the uterus, for example, the mucosa, its inner lining, and the muscular layer did not change in sync. These tissues also appeared to be particularly sensitive to the hormonal and biological shifts associated with menopause.

Marta Melé, leader of the transcriptomics and functional genomics group at BSC and director of the study, said: “Our results show that it acts as a turning point that profoundly reorganises other organs and tissues of the reproductive system, and allows us to identify the genes and molecular processes that could be behind these changes.”

Building on the finding that organs age according to different patterns, co-first author Laura Ventura said the research “paves the way for personalised medicine where treatments are tailored to a woman’s specific molecular profile and the specific tissues showing the most age-related distress.”

The study also identified molecular signals linked to reproductive ageing that can be detected in blood samples from more than 21,441 women.

These biomarkers could allow doctors to monitor the condition of reproductive organs in a non-invasive way, potentially helping to anticipate risks such as pelvic floor complications without the need for biopsies.

According to the researchers, this could lead to simpler and more accessible clinical tools for tracking women’s health over time.

Continue Reading

Cancer

Ovarian cancer cases rising among younger adults, study finds

Published

on

Ovarian cancer cases are rising among younger adults in England, with bowel cancer showing a similar pattern, a new study suggests.

Researchers said excess weight is a key contributor, but is unlikely on its own to explain the pattern.

The authors wrote: “These patterns suggest that while similar risk factors across ages are likely, some cancers may have age-specific exposures, susceptibilities, or differences in screening and detection practices.”

They added: “Although overweight and obesity are linked to 10 of the 11 cancers evaluated and account for a substantial proportion of cancer cases, both BMI-attributable and BMI-non-attributable incidence rates have increased, though the latter more slowly, suggesting other contributors.”

The study analysed cancer incidence, meaning new diagnoses, in England between 2001 and 2019 across more than 20 cancer types, comparing adults aged 20 to 49 with those aged 50 and over.

Among younger women, cases of 16 out of 22 cancers increased significantly over the period, while among younger men, 11 out of 21 cancers increased significantly.

In particular, there was a significant rise in 11 cancers with known behavioural risk factors among adults under 50. These were thyroid, multiple myeloma, liver, kidney, gallbladder, bowel, pancreatic, endometrial, mouth, breast and ovarian cancers.

Rates of all 11 also rose significantly among adults aged 50 and over, with the notable exceptions of bowel and ovarian cancer.

Five cancers, endometrial, kidney, pancreatic, multiple myeloma and thyroid cancer, increased significantly faster in younger than in older women, while multiple myeloma increased faster in younger than in older men.

The researchers looked at established risk factors including smoking, alcohol intake, diet, physical inactivity and body mass index, a measure used to assess whether someone is underweight, a healthy weight, overweight or obese.

With the exception of mouth cancer, all 11 cancers were associated with obesity. Six, liver, bowel, mouth, pancreatic, kidney and ovarian, were also linked to smoking.

Four, liver, bowel, mouth and breast, were associated with alcohol intake. Three, bowel, breast and endometrial, were linked to physical inactivity, and one, bowel, was associated with dietary factors.

But apart from excess weight, trends in those risk factors over the past one to two decades were stable or improving among younger adults.

That suggests other factors may also play a part, including reproductive history, early-life or prenatal exposures, and changes in diagnosis and detection.

The study noted that red meat consumption fell among younger adults, while fibre intake remained stable or slightly improved in both sexes between 2009 and 2019, although more than 90 per cent of younger adults were still not eating enough fibre in 2018.

Established behavioural risk factors accounted for a substantial share of cancer cases.

Excess weight was the risk factor associated with most cancers in 2019, ranging from 5 per cent for ovarian cancer to 37 per cent for endometrial cancer.

The researchers said the findings were based on observational data, meaning the study could identify patterns but could not prove cause and effect.

They also noted there were no consistent long-term national data for several risk factors, that the analysis was limited to England rather than the UK, and that cancer remains far more common overall in older adults despite the rise in cases among younger people.

Continue Reading

Pregnancy

Early miscarriage care could prevent 10,000 pregnancy losses a year, study finds

Published

on

Early miscarriage care after a first loss could prevent about 10,000 pregnancy losses a year in the UK, according to a new study.

The study by Tommy’s National Centre for Miscarriage Research and Birmingham women’s hospital involving 406 women found a 4 per cent reduction in the risk of future miscarriage for women on the graded model of care compared with usual care.

Women in England, Wales and Northern Ireland currently become eligible for specialised NHS care for early baby loss only after they have had at least three miscarriages.

Tommy’s has called for women to become eligible after one miscarriage, saying this could reduce the risk of future miscarriages and improve health outcomes for mothers.

Researchers said that would translate to 10,075 fewer miscarriages a year across the UK.

Kath Abrahams, chief executive of Tommy’s, said women were being “left without early access to services that could help prevent future losses and reduce the debilitating feelings of isolation and hopelessness that we know affect so many who experience pregnancy loss”.

She said: “Our pilot study indicates that providing support after a first miscarriage, with escalating care after further losses, is not only effective but achievable without significant additional workload for NHS teams who are already working extremely hard to deliver good care.

“Put simply, it is the right thing to do. We will do all we can to drive that change across the UK so that more women and families are supported after every miscarriage.”

The graded model of miscarriage care proposed by Tommy’s is already available in Scotland, and the charity is calling for it to be introduced across the whole of the UK.

The graded model includes nurse-led support after one miscarriage, with advice on reducing risk factors such as low vitamin D, folic acid intake, alcohol consumption and caffeine use.

Women who received the specialised care were 47 per cent more likely to have a risk factor identified and receive relevant advice to help prevent future miscarriages than women receiving usual care, the study found.

Among women who had experienced two miscarriages and received the specialised care, one in five were found to have thyroid dysfunction or anaemia, both conditions that can affect pregnancy outcomes.

About one in four pregnancies ends in miscarriage, most often within the first 12 weeks of pregnancy.

The report comes ahead of the long-awaited final findings of the government’s investigation into maternity care in England. Interim findings uncovered a range of failures, including claims that NHS hospitals that caused harm to women and babies during childbirth often resorted to a “cover-up” of their mistakes, falsified medical records and denied bereaved parents answers.

Women’s health minister Gillian Merron said: “Pregnancy and baby loss can have a devastating impact on women and families, who too often feel they have been left without the care and support they need.

“I welcome the findings of this important report, and this will be carefully considered as part of our ongoing work to make sure women get the high-quality, compassionate NHS care they deserve.”

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.